Virtus ETF Advisers’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-22,368
| Closed | -$159K | – | 492 |
|
|
2020
Q1 | $159K | Sell |
22,368
-1,887
| -8% | -$13.4K | 0.07% | 286 |
|
|
2019
Q4 | $579K | Sell |
24,255
-2,655
| -10% | -$63.4K | 0.09% | 193 |
|
|
2019
Q3 | $722K | Sell |
26,910
-4,526
| -14% | -$121K | 0.15% | 160 |
|
|
2019
Q2 | $853K | Buy |
+31,436
| New | +$853K | 0.18% | 168 |
|
|
2019
Q1 | – | Sell |
-32,607
| Closed | -$636K | – | 292 |
|
|
2018
Q4 | $636K | Buy |
32,607
+13,746
| +73% | +$268K | 0.11% | 39 |
|
|
2018
Q3 | $502K | Buy |
18,861
+1,271
| +7% | +$33.8K | 0.05% | 121 |
|
|
2018
Q2 | $664K | Sell |
17,590
-1,613
| -8% | -$60.9K | 0.59% | 118 |
|
|
2018
Q1 | $627K | Sell |
19,203
-1,115
| -5% | -$36.4K | 0.54% | 101 |
|
|
2017
Q4 | $989K | Buy |
20,318
+11,378
| +127% | +$554K | 1.24% | 22 |
|
|
2017
Q3 | $483K | Buy |
8,940
+818
| +10% | +$44.2K | 0.07% | 93 |
|
|
2017
Q2 | $456K | Sell |
8,122
-7,246
| -47% | -$407K | 0.07% | 74 |
|
|
2017
Q1 | $602K | Buy |
15,368
+1,473
| +11% | +$57.7K | 0.11% | 96 |
|
|
2016
Q4 | $312K | Buy |
13,895
+4,160
| +43% | +$93.4K | 0.09% | 109 |
|
|
2016
Q3 | $221K | Hold |
9,735
| – | – | 0.11% | 131 |
|
|
2016
Q2 | $230K | Buy |
9,735
+4,503
| +86% | +$106K | 0.17% | 114 |
|
|
2016
Q1 | $107K | Sell |
5,232
-329
| -6% | -$6.73K | 0.15% | 142 |
|
|
2015
Q4 | $286K | Buy |
+5,561
| New | +$286K | 0.79% | 36 |
|